Morgan Stanley Portfolio holdings
Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2101
KB Home
KBH
$2.9B
| $56.8M | ﹤0.01% |
907,781
+16,279
| +2% | +$847K |
2013 Q2
52 quarters
|
|
2102
Tetra Tech
TTEK
$9.8B
| $56.8M | ﹤0.01% |
1,966,257
-273,247
| -12% | -$8.02M |
2013 Q2
52 quarters
|
|
2103
Simmons First National
SFNC
$3.38B
| $56.7M | ﹤0.01% |
2,503,393
+898,495
| +56% | +$19.2M |
2013 Q2
52 quarters
|
|
2104
Knowles
KN
$2.96B
| $56.6M | ﹤0.01% |
1,365,364
+314,729
| +30% | +$10.9M |
2014 Q1
49 quarters
|
|
2105
iShares Core US REIT ETF
USRT
$4.29B
| $56.6M | ﹤0.01% |
852,214
-101,041
| -11% | -$6.51M |
2013 Q2
52 quarters
|
|
2106
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.51B
| $56.6M | ﹤0.01% |
1,877,709
-68,692
| -4% | -$2.06M |
2013 Q2
52 quarters
|
|
2107
Copa Holdings
CPA
$5.36B
| $56.6M | ﹤0.01% |
363,505
+42,905
| +13% | +$5.58M |
2013 Q2
52 quarters
|
|
2108
Aberdeen Multi-Market Income Fund
MMT
$227M
| $56.3M | ﹤0.01% |
12,794,540
+10,202,366
| +394% | +$46.2M |
2013 Q2
52 quarters
|
|
2109
Vanguard Russell 2000 Value ETF
VTWV
$1.34B
| $56.2M | ﹤0.01% |
287,799
+89,712
| +45% | +$16.6M |
2013 Q2
52 quarters
|
|
2110
Amylyx Pharmaceuticals
AMLX
$3.6B
| $56.2M | ﹤0.01% |
3,130,808
+955,261
| +44% | +$14.8M |
2022 Q1
17 quarters
|
|
2111
Newell Brands
NWL
$2.16B
| $56M | ﹤0.01% |
9,121,138
-417,807
| -4% | -$1.77M |
2013 Q2
52 quarters
|
|
2112
First Trust Intermediate Duration Investment Grade Corporate ETF
FIIG
$635M
| $56M | ﹤0.01% |
2,702,158
+155,672
| +6% | +$3.23M |
2024 Q1
9 quarters
|
|
2113
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.27B
| $55.9M | ﹤0.01% |
612,281
+1,763
| +0.3% | +$157K |
2013 Q2
52 quarters
|
|
2114
Bio-Rad Laboratories Class A
BIO
$10.3B
| $55.9M | ﹤0.01% |
190,285
-83,646
| -31% | -$23.7M |
2013 Q2
52 quarters
|
|
2115
WisdomTree Enhanced Commodity Strategy Fund
GCC
$248M
| $55.9M | ﹤0.01% |
2,465,865
+91,620
| +4% | +$2.25M |
2013 Q2
52 quarters
|
|
2116
Group 1 Automotive
GPI
$3.1B
| $55.8M | ﹤0.01% |
191,776
+6,134
| +3% | +$2.01M |
2013 Q2
52 quarters
|
|
2117
Credit Acceptance
CACC
$5.98B
| $55.8M | ﹤0.01% |
87,613
+11,189
| +15% | +$5.99M |
2013 Q2
52 quarters
|
|
2118
Trinity Industries
TRN
$2.26B
| $55.7M | ﹤0.01% |
1,610,059
-89,279
| -5% | -$3.02M |
2013 Q2
52 quarters
|
|
2119
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
| $55.7M | ﹤0.01% |
2,401,540
+14,102
| +0.6% | +$314K |
2013 Q2
52 quarters
|
|
2120
Tortoise Energy Infrastructure Corp
TYG
$1.02B
| $55.7M | ﹤0.01% |
1,298,404
+149,107
| +13% | +$6.85M |
2013 Q2
52 quarters
|
|
2121
iShares TLT Premium Income+ ETF
TLTW
$1.6B
| $55.6M | ﹤0.01% |
2,490,239
+554,604
| +29% | +$12.4M |
2023 Q3
11 quarters
|
|
2122
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$600M
| $55.5M | ﹤0.01% |
277,568
+35,123
| +14% | +$6.39M |
2013 Q2
52 quarters
|
|
2123
Brookdale Senior Living
BKD
$2.45B
| $55.4M | ﹤0.01% |
3,446,212
+951,437
| +38% | +$12.9M |
2013 Q2
52 quarters
|
|
2124
Nova
NVMI
$10.6B
| $55.4M | ﹤0.01% |
102,126
+19,429
| +23% | +$10M |
2013 Q2
52 quarters
|
|
2125
Global X Variable Rate Preferred ETF
PFFV
$333M
| $55.3M | ﹤0.01% |
2,511,491
+219,231
| +10% | +$4.87M |
2022 Q1
17 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.